Wednesday, July 8, 2026

pharma · Non-transfusion-dependent Thalassemia · Advanced Solid Tumors · SLN

Silence Therapeutics

News and analysis for Silence Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

London, GB HQ
1999 Founded
91 Employees
Public company Type
SLN · NYSE Ticker
Company details
Status
Public
HQ
London, GB
Founded
1999
Employees
91
Programs
8
Drugs
6
Patents
3
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Silence Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Silence Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Silence Therapeutics yet.

Back to company overview →